首页> 外文期刊>Phytomedicine : >Therapeutic efficacy of Stephania tetrandra S. Moore for treatment of neovascularization of retinal capillary (retinopathy) in diabetes--in vitro study.
【24h】

Therapeutic efficacy of Stephania tetrandra S. Moore for treatment of neovascularization of retinal capillary (retinopathy) in diabetes--in vitro study.

机译:千金藤(Stephaniatetrandra S.Moore)在糖尿病视网膜毛细血管新生血管形成(视网膜病变)中的治疗效果-体外研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The present study was designed to examine therapeutic efficacy of the root extract of Stephania Tetrandra S. Moore (STMS) (traditional Chinese medicine; Han Fang Ji) for treatment of neovascularization of the retinal capillary (retinopathy) in streptozotocin (STZ)-induced diabetic rats (STZ diabetic rats) in culture. Recently we have established the culture system in which fetal bovine serum (FBS) in Dulbecco modified Eagle medium (DMEM) induced neovascularization of the retinal capillary and choroidal capillary in normal rats in culture. STZ diabetic rats showed more neovascularization of the retinal capillary and choroidal capillary than did normal rats in culture. In this study, the retinal tissue was removed for the posterior ocular region and cultured in DMEM containing FBS. The choroidal tissue of the posterior ocular region was also removed and cultured as an internal reference. Administration of STSM (0.91, 9.1 and 91 microg/ml) significantly suppressed neovascularization of the retinal capillary in both STZ diabetic rats and normal rats in a dose-dependent manner. Similar results were obtained with the choroidal capillary; administration of STSM suppressed neovascularization of the choroidal capillary in both STZ diabetic rats and normal rats. In order to determine the component of STSM inhibiting neovascularization of the retinal capillary, tetrandrine (a major chemical constituent of STSM) was administered and neovascularization of the retinal capillary was examined in culture. The effect of tetrandrine on the choroidal capillary was also examined as an internal reference. Administration of tetrandrine (0.1, 1.0 and 10 microM) suppressed neovascularization of the retinal capillary in both STZ diabetic rats and normal rats in a dose-dependent manner. Similar results were obtained with the choroidal capillary of both STZ diabetic rats and normal rats. We infer, therefore, that STSM has a direct effect on the retinal capillary of posterior ocular region and suppresses neovascularization of retinal capillary in STZ diabetic rats through the activation of tetrandrine. These results suggest that STSM may prevent for delay the progression of retinopathy in diabetic patients.
机译:本研究旨在探讨千金藤(STMS)(中药;韩芳济)根提取物在链脲佐菌素(STZ)诱导的糖尿病中治疗视网膜毛细血管新生血管(视网膜病变)的疗效。大鼠(STZ糖尿病大鼠)培养。最近,我们建立了一种培养系统,其中Dulbecco改良Eagle培养基(DMEM)中的胎牛血清(FBS)在培养的正常大鼠中诱导视网膜毛细血管和脉络膜毛细血管的新生血管形成。 STZ糖尿病大鼠的视网膜毛细血管和脉络膜毛细血管的新血管形成比正常培养的大鼠多。在这项研究中,去除了眼后部的视网膜组织,并在含有FBS的DMEM中进行培养。眼后区域的脉络膜组织也被去除并作为内部参照进行培养。在STZ糖尿病大鼠和正常大鼠中,STSM(0.91、9.1和91 microg / ml)的给药显着抑制了视网膜毛细血管的新生血管形成,且呈剂量依赖性。脉络膜毛细管获得了相似的结果。在STZ糖尿病大鼠和正常大鼠中,施用STSM均可抑制脉络膜毛细血管的新生血管形成。为了确定STSM抑制视网膜毛细血管新生的成分,给予粉防己碱(STSM的主要化学成分),并在培养物中检查视网膜毛细血管的新生血管。还检查了粉防己碱对脉络膜毛细血管的作用作为内部参考。粉防己碱(0.1、1.0和10 microM)的给药以剂量依赖性方式抑制了STZ糖尿病大鼠和正常大鼠的视网膜毛细血管新生血管。 STZ糖尿病大鼠和正常大鼠的脉络膜毛细血管获得了相似的结果。因此,我们推断,STSM对后眼区视网膜毛细血管具有直接作用,并通过粉防己碱的激活抑制STZ糖尿病大鼠视网膜毛细血管的新生血管形成。这些结果表明,STSM可以预防糖尿病患者视网膜病变的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号